Clujul Medical 4 - Clujul Medical - Iuliu Haţieganu

Clujul Medical 2008 vol. LXXXI – nr.4 432
8. J ISCOVICH, R CASTELLETTO, J ESTEVE, N MUNOZ - Tobacco smoking, occupational
exposure and bladder cancer in Argentina, International Journal of Cancer, 40 (6), 734-740, dec 15,
1987;
9. TM MACK, MC YU, R HANISCH - Pancreas cancer and smoking beverage consumption and past
medical history, Journal of the National Cancer Institute 76(1), 49-60, 1986;
10. JM CARSTENSEN, G PERSHAGEN, G EKLAND: Mortality in relation to cigarette and pipe
smoking: 16 years observation of 25000 Swedish men, Journal of Epidemiology and Community Health
41 : 166-172, 1987;
11. J CUZICK, AG BABIKER - Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease,
International Journal of Cancer 43(3), 415-421, 1989;
12. WYNDER EL, R GOLDSMITH - The epidemiology of bladder cancer. A second look, Cancer 40
(3), 1246-1268, 1977;
13. IM SASSON, MJ HALEY, D HOFFMANN, EL WYNDER, D HELLBERG - Cigarette smoking
and neoplasia of the uterine cervix: smoke constituents in cervical mucus, NEJM 312 (5), 315-316, Jan
31, 1985;
14. R GOLDBERG, M SZKLO, V CHANDRA - The effect of cigarette smoking on the long-term
prognosis of myocardial infarction, American Journal of Epidemiology, 114(3):431, 1981;
15. KM GALAN, U DELIGONUL, MJ KERN - Increased frequency of restenosis in patients continuing
to smoke cigarettes after percutaneous transluminal coronary angioplasty, American Lournal of
Cardiology, 61:260-263, 1988;
16. R SHINTON, G BEEVERS - Meta-analysis of relation between cigarette smoking and stroke, BMJ
29, 789-794, 1989;
17. A SOMESAN, GH DANCAU - Fumatul-implicatii etiopatogenetice in bolile respiratorii cornice şi
ulcerul gastro-duodenal, Med Moderna, vol 14, nr8, aug 2006,
18. BWM WILLEMSE, DS POSTMA, W TIMENS, NH HACKEN - The impact of smoking cessation
on respiratory symptoms, lung function, aitway hyperresponsiveness and inflammation, Eur Resp J,
23:464-476, 2004;
19. RE KANNER, JE CONNETT, DE WILLIAMS, AS BUIST - Effects of randomized assignment to a
smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with
early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999;106:410–416;
20. C FLETCHER, R PETO. The natural history of chronic airflow obstruction. BMJ 1977;1:1645–1648;
21. TK LIM, RG TAYLOR, A WATSON, JOYCE PRIDE NB. Changes in bronchial responsiveness to
inhaled histamine over four years in middle aged male smokers and ex-smokers. Thorax 1988;43:599–
604
22. CM SKOLD, J HED, A EKLUND. Smoking cessation rapidly reduces cell recovery in
bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. Chest
1992;101:989–995
The benefits of stoping tobacco epidemic
DOINA ADINA TODEA, NICOLETA ARIEŞANU, LOREDANA ELENA ROŞCA,
ANDREEA CRISTINA HERESCU
Summary
Now tobacco smoking is considered to be an devastating epidemic and fighthing against tobacco
smoking is a main objective of World Health Organization (WHO). By 2030 there will be more than 8
million deaths every year and one billion estimated deaths during the 21st century because of tobacco
smoking. Tobacco use is a risk factor for six of the eight leading causes of death. Smoking cessation is
important for the immediately and long term benefits and health problems represents one of the most
important factors that favours smoking cessation.
Key words: smoking, respiratory diseases, cardiovascular diseases.